MedPath

Metabolic Syndrome Cohort in Korea

Withdrawn
Conditions
Metabolic Syndrome
Registration Number
NCT02077530
Lead Sponsor
Korea University Anam Hospital
Brief Summary

Patients with metabolic syndrome living in Seoul area are included in this prospective registry for more than 10 years. All enrolled patients undergo thorough medical history survey. Enrolled patients will have coronary CT, 2D echocardiogram, treadmill test, pulse wave velocity, augmentation index, carotid intima-media thickness, and abdominal fat mass evaluation. Moreover, lipid profiles and inflammatory markers such as hsCRP, IL-6, TNF-alpha, VCAM-1, ICAM-1, adiponectin, MMP-9 will be measured. All participants will repeat the test and survey every year in Korea University Hospital.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

3 out of 5 criteria

  • Central obesity: Men ≥ 90 cm Women ≥ 85 cm
  • Plasma triglycerides ≥ 150 mg/dL
  • HDL cholesterol Men < 40 mg/dL, Women < 50 mg/dL
  • Blood pressure ≥130/85 mm Hg (or treatment for hypertension)
  • Fasting plasma glucose ≥ 100 mg/dL
  • Age between 30 to 64
  • Consent to our registry protocol
Exclusion Criteria
  • Patients who could not undergo coronary CT, 2D echocardiogram, treadmill test, and pulse wave velocity.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cardiovascular events10 years

Cardiovascular events such as fatal and non-fatal myocardial infarction, heart failure, need for coronary and peripheral revascularization, stroke, all-cause death, and cardiac death.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Korea University Anam Hospital Metabolic Syndrome Research Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath